Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Head and Neck Cancer

  Free Subscription


Articles published in Br J Cancer

Retrieve available abstracts of 110 articles:
HTML format



Single Articles


    July 2021
  1. WU P, Xie C, Yang L, Liu Y, et al
    The genomic architectures of tumour-adjacent tissues, plasma and saliva reveal evolutionary underpinnings of relapse in head and neck squamous cell carcinoma.
    Br J Cancer. 2021 Jul 6. pii: 10.1038/s41416-021-01464.
    PubMed     Abstract available


    June 2021
  2. SULKSHANE P, Pawar SN, Waghole R, Pawar SS, et al
    Elevated USP9X drives early-to-late-stage oral tumorigenesis via stabilisation of anti-apoptotic MCL-1 protein and impacts outcome in oral cancers.
    Br J Cancer. 2021 Jun 2. pii: 10.1038/s41416-021-01421.
    PubMed     Abstract available


    May 2021
  3. JENSEN KH, Vogelius I, Moser CE, Andersen E, et al
    Bloodstream infections in head and neck cancer patients after curative-intent radiotherapy: a population-based study from the Danish Head and Neck Cancer Group database.
    Br J Cancer. 2021 May 20. pii: 10.1038/s41416-021-01430.
    PubMed     Abstract available


    April 2021
  4. MAHMOOD H, Shaban M, Rajpoot N, Khurram SA, et al
    Artificial Intelligence-based methods in head and neck cancer diagnosis: an overview.
    Br J Cancer. 2021 Apr 19. pii: 10.1038/s41416-021-01386.
    PubMed     Abstract available


    March 2021
  5. CHEN Y, Maniakas A, Tan L, Cui M, et al
    Development of a rational strategy for integration of lactate dehydrogenase A suppression into therapeutic algorithms for head and neck cancer.
    Br J Cancer. 2021 Mar 19. pii: 10.1038/s41416-021-01297.
    PubMed     Abstract available


    February 2021
  6. NG SP, Bahig H, Jethanandani A, Sturgis EM, et al
    Prognostic significance of pre-treatment neutrophil-to-lymphocyte ratio (NLR) in patients with oropharyngeal cancer treated with radiotherapy.
    Br J Cancer. 2021;124:628-633.
    PubMed     Abstract available


  7. KILLCOYNE S, Fitzgerald RC
    Practical early cancer detection: distinguishing stable from unstable genomes in pre-cancerous tissues.
    Br J Cancer. 2021;124:683-685.
    PubMed     Abstract available


    December 2020
  8. KIM HR, Kang HN, Yun MR, Ju KY, et al
    Mouse-human co-clinical trials demonstrate superior anti-tumour effects of buparlisib (BKM120) and cetuximab combination in squamous cell carcinoma of head and neck.
    Br J Cancer. 2020;123:1720-1729.
    PubMed     Abstract available


  9. PATEL U, Pandey M, Kannan S, Samant TA, et al
    Prognostic and predictive significance of nuclear HIF1alpha expression in locally advanced HNSCC patients treated with chemoradiation with or without nimotuzumab.
    Br J Cancer. 2020;123:1757-1766.
    PubMed     Abstract available


    November 2020
  10. BAXTER MA, Spender LC, Petty RD
    Combining precision medicine and prophylaxis in oesophageal squamous cell carcinoma.
    Br J Cancer. 2020;123:1585-1587.
    PubMed     Abstract available


  11. XIE C, Jing Z, Luo H, Jiang W, et al
    Chemoradiotherapy with extended nodal irradiation and/or erlotinib in locally advanced oesophageal squamous cell cancer: long-term update of a randomised phase 3 trial.
    Br J Cancer. 2020;123:1616-1624.
    PubMed     Abstract available


    October 2020
  12. OPENSHAW MR, Mohamed AA, Ottolini B, Fernandez-Garcia D, et al
    Longitudinal monitoring of circulating tumour DNA improves prognostication and relapse detection in gastroesophageal adenocarcinoma.
    Br J Cancer. 2020;123:1271-1279.
    PubMed     Abstract available


  13. WANG Y, Li Q, Niu L, Xu L, et al
    Suppression of G6PD induces the expression and bisecting GlcNAc-branched N-glycosylation of E-Cadherin to block epithelial-mesenchymal transition and lymphatic metastasis.
    Br J Cancer. 2020;123:1315-1325.
    PubMed     Abstract available


  14. CAPONIO VCA, Troiano G, Adipietro I, Zhurakivska K, et al
    Computational analysis of TP53 mutational landscape unveils key prognostic signatures and distinct pathobiological pathways in head and neck squamous cell cancer.
    Br J Cancer. 2020;123:1302-1314.
    PubMed     Abstract available


    September 2020
  15. DHARMAWARDANA N, Goddard T, Woods C, Watson DI, et al
    Development of a non-invasive exhaled breath test for the diagnosis of head and neck cancer.
    Br J Cancer. 2020 Sep 9. pii: 10.1038/s41416-020-01051.
    PubMed     Abstract available


    August 2020
  16. DI CREDICO G, Polesel J, Dal Maso L, Pauli F, et al
    Alcohol drinking and head and neck cancer risk: the joint effect of intensity and duration.
    Br J Cancer. 2020 Aug 24. pii: 10.1038/s41416-020-01031.
    PubMed     Abstract available


  17. ELKASHTY OA, Tran SD
    Broccoli extract increases drug-mediated cytotoxicity towards cancer stem cells of head and neck squamous cell carcinoma.
    Br J Cancer. 2020 Aug 10. pii: 10.1038/s41416-020-1025.
    PubMed     Abstract available


  18. YAMAMOTO T, Hirosue A, Nakamoto M, Yoshida R, et al
    BRD4 promotes metastatic potential in oral squamous cell carcinoma through the epigenetic regulation of the MMP2 gene.
    Br J Cancer. 2020;123:580-590.
    PubMed     Abstract available


    July 2020
  19. HUTCHISON I, Hackshaw A
    Reply to Comment(s) on "Nationwide randomised trial evaluating elective neck dissection for early stage oral cancer (SEND study) with meta-analysis and concurrent real-world cohort".
    Br J Cancer. 2020 Jul 16. pii: 10.1038/s41416-020-0983.
    PubMed    


  20. DHAR H, Vaish R, D'Cruz AK
    Comment on "Nationwide randomised trial evaluating elective neck dissection for early-stage oral cancer (SEND study) with meta-analysis and concurrent real-world cohort."
    Br J Cancer. 2020 Jul 16. pii: 10.1038/s41416-020-0981.
    PubMed    


  21. SINGH A, Subash A, Sinha P
    Comment on "Nationwide randomised trial evaluating elective neck dissection for early stage oral cancer (SEND study) with meta-analysis and concurrent real-world cohort".
    Br J Cancer. 2020 Jul 16. pii: 10.1038/s41416-020-0982.
    PubMed    


  22. WAGNER S, Prigge ES, Wuerdemann N, Reder H, et al
    Evaluation of p16(INK4a) expression as a single marker to select patients with HPV-driven oropharyngeal cancers for treatment de-escalation.
    Br J Cancer. 2020 Jul 6. pii: 10.1038/s41416-020-0964.
    PubMed     Abstract available


  23. XU K, Fu Y, Han Y, Xia R, et al
    Fewer tumour-specific PD-1(+)CD8(+) TILs in high-risk "Infiltrating" HPV(-) HNSCC.
    Br J Cancer. 2020 Jul 3. pii: 10.1038/s41416-020-0966.
    PubMed     Abstract available


  24. RONG C, Muller MF, Xiang F, Jensen A, et al
    Adaptive ERK signalling activation in response to therapy and in silico prognostic evaluation of EGFR-MAPK in HNSCC.
    Br J Cancer. 2020;123:288-297.
    PubMed     Abstract available


  25. CHEN X, Zhuo S, Xu W, Chen X, et al
    Isocitrate dehydrogenase 2 contributes to radiation resistance of oesophageal squamous cell carcinoma via regulating mitochondrial function and ROS/pAKT signalling.
    Br J Cancer. 2020;123:126-136.
    PubMed     Abstract available


  26. KAGOHARA LT, Zamuner F, Davis-Marcisak EF, Sharma G, et al
    Integrated single-cell and bulk gene expression and ATAC-seq reveals heterogeneity and early changes in pathways associated with resistance to cetuximab in HNSCC-sensitive cell lines.
    Br J Cancer. 2020;123:101-113.
    PubMed     Abstract available


    June 2020
  27. MORVAN VL, Richard E, Cadars M, Fessart D, et al
    Cytochrome P450 1B1 polymorphism drives cancer cell stemness and patient outcome in head-and-neck carcinoma.
    Br J Cancer. 2020 Jun 22. pii: 10.1038/s41416-020-0932.
    PubMed     Abstract available


  28. BAYSAL H, De Pauw I, Zaryouh H, De Waele J, et al
    Cetuximab-induced natural killer cell cytotoxicity in head and neck squamous cell carcinoma cell lines: investigation of the role of cetuximab sensitivity and HPV status.
    Br J Cancer. 2020 Jun 16. pii: 10.1038/s41416-020-0934.
    PubMed     Abstract available


  29. SHAH SC, Dai Q, Zhu X, Peek RM Jr, et al
    Associations between calcium and magnesium intake and the risk of incident oesophageal cancer: an analysis of the NIH-AARP Diet and Health Study prospective cohort.
    Br J Cancer. 2020;122:1857-1864.
    PubMed     Abstract available


    May 2020
  30. KIM JH, Han KD, Lee JK, Kim HS, et al
    Association between the National Cancer Screening Programme (NSCP) for gastric cancer and oesophageal cancer mortality.
    Br J Cancer. 2020 May 13. pii: 10.1038/s41416-020-0883.
    PubMed     Abstract available


  31. RASMUSSEN JH, Olin A, Lelkaitis G, Hansen AE, et al
    Does multiparametric imaging with (18)F-FDG-PET/MRI capture spatial variation in immunohistochemical cancer biomarkers in head and neck squamous cell carcinoma?
    Br J Cancer. 2020 May 8. pii: 10.1038/s41416-020-0876.
    PubMed     Abstract available


  32. KO JM, Vardhanabhuti V, Ng WT, Lam KO, et al
    Clinical utility of serial analysis of circulating tumour cells for detection of minimal residual disease of metastatic nasopharyngeal carcinoma.
    Br J Cancer. 2020 May 6. pii: 10.1038/s41416-020-0871.
    PubMed     Abstract available


  33. OKADOME K, Baba Y, Nomoto D, Yagi T, et al
    Prognostic and clinical impact of PD-L2 and PD-L1 expression in a cohort of 437 oesophageal cancers.
    Br J Cancer. 2020;122:1535-1543.
    PubMed     Abstract available


  34. TOGO M, Yokobori T, Shimizu K, Handa T, et al
    Diagnostic value of (18)F-FDG-PET to predict the tumour immune status defined by tumoural PD-L1 and CD8(+)tumour-infiltrating lymphocytes in oral squamous cell carcinoma.
    Br J Cancer. 2020;122:1686-1694.
    PubMed     Abstract available


  35. KIM MH, Kim JH, Lee JM, Choi JW, et al
    Molecular subtypes of oropharyngeal cancer show distinct immune microenvironment related with immune checkpoint blockade response.
    Br J Cancer. 2020;122:1649-1660.
    PubMed     Abstract available


    February 2020
  36. ISHII H, Saitoh M, Sakamoto K, Sakamoto K, et al
    Lipidome-based rapid diagnosis with machine learning for detection of TGF-beta signalling activated area in head and neck cancer.
    Br J Cancer. 2020 Feb 5. pii: 10.1038/s41416-020-0732.
    PubMed     Abstract available


  37. PORTER RJ, Murray GI, Brice DP, Petty RD, et al
    Novel biomarkers for risk stratification of Barrett's oesophagus associated neoplastic progression-epithelial HMGB1 expression and stromal lymphocytic phenotype.
    Br J Cancer. 2020;122:545-554.
    PubMed     Abstract available


  38. TSAKIROGLOU AM, Fergie M, Oguejiofor K, Linton K, et al
    Spatial proximity between T and PD-L1 expressing cells as a prognostic biomarker for oropharyngeal squamous cell carcinoma.
    Br J Cancer. 2020;122:539-544.
    PubMed     Abstract available


  39. HATOGAI K, Fujii S, Kitano S, Kojima T, et al
    Relationship between the immune microenvironment of different locations in a primary tumour and clinical outcomes of oesophageal squamous cell carcinoma.
    Br J Cancer. 2020;122:413-420.
    PubMed     Abstract available


    January 2020
  40. JESINGHAUS M, Steiger K, Stogbauer F, Haller B, et al
    Pre-operative cellular dissociation grading in biopsies is highly predictive of post-operative tumour stage and patient outcome in head and neck squamous cell carcinoma.
    Br J Cancer. 2020 Jan 15. pii: 10.1038/s41416-019-0719.
    PubMed     Abstract available


  41. CHANG CP, La Vecchia C, Serraino D, Olshan AF, et al
    Dietary glycaemic index, glycaemic load and head and neck cancer risk: a pooled analysis in an international consortium.
    Br J Cancer. 2020 Jan 13. pii: 10.1038/s41416-019-0702.
    PubMed     Abstract available


    December 2019
  42. SHEN B, Huang D, Ramsey AJ, Ig-Izevbekhai K, et al
    PD-L1 and MRN synergy in platinum-based chemoresistance of head and neck squamous cell carcinoma.
    Br J Cancer. 2019 Dec 19. pii: 10.1038/s41416-019-0697.
    PubMed     Abstract available


  43. ZHANG W, Cheng J, Diao P, Wang D, et al
    Therapeutically targeting head and neck squamous cell carcinoma through synergistic inhibition of LSD1 and JMJD3 by TCP and GSK-J1.
    Br J Cancer. 2019 Dec 18. pii: 10.1038/s41416-019-0680.
    PubMed     Abstract available


  44. LI B, Liao Z, Mo Y, Zhao W, et al
    Inactivation of 3-hydroxybutyrate dehydrogenase type 2 promotes proliferation and metastasis of nasopharyngeal carcinoma by iron retention.
    Br J Cancer. 2019 Dec 10. pii: 10.1038/s41416-019-0638.
    PubMed     Abstract available


  45. ZHANG Z, Liu R, Shuai Y, Huang Y, et al
    ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma.
    Br J Cancer. 2019 Dec 10. pii: 10.1038/s41416-019-0637.
    PubMed     Abstract available


    November 2019
  46. SABATINI ME, Chiocca S
    Human papillomavirus as a driver of head and neck cancers.
    Br J Cancer. 2019 Nov 11. pii: 10.1038/s41416-019-0602.
    PubMed     Abstract available


    October 2019
  47. BECKHAM TH, Leeman JE, Xie P, Li X, et al
    Long-term survival in patients with metastatic head and neck squamous cell carcinoma treated with metastasis-directed therapy.
    Br J Cancer. 2019 Oct 25. pii: 10.1038/s41416-019-0601.
    PubMed     Abstract available


  48. HUTCHISON IL, Ridout F, Cheung SMY, Shah N, et al
    Nationwide randomised trial evaluating elective neck dissection for early stage oral cancer (SEND study) with meta-analysis and concurrent real-world cohort.
    Br J Cancer. 2019 Oct 15. pii: 10.1038/s41416-019-0587.
    PubMed     Abstract available


    September 2019
  49. NICHOLLS JM, Lee VH, Chan SK, Tsang KC, et al
    Negative plasma Epstein-Barr virus DNA nasopharyngeal carcinoma in an endemic region and its influence on liquid biopsy screening programmes.
    Br J Cancer. 2019 Sep 17. pii: 10.1038/s41416-019-0575.
    PubMed     Abstract available


    June 2019
  50. FITZGERALD RC, Rhodes JM
    Ingested asbestos in filtered beer, in addition to occupational exposure, as a causative factor in oesophageal adenocarcinoma.
    Br J Cancer. 2019;120:1099-1104.
    PubMed     Abstract available


    May 2019
  51. HADLER-OLSEN E, Wirsing AM
    Reply to 'Comment on "Tissue-infiltrating immune cells as prognostic markers in oral squamous cell carcinoma: a systematic review and meta-analysis"'.
    Br J Cancer. 2019;120:1084-1085.
    PubMed    


  52. ZHOU L, Li M, Zhu T
    Comment on 'Tissue-infiltrating immune cells as prognostic markers in oral squamous cell carcinoma: a systematic review and meta-analysis'.
    Br J Cancer. 2019;120:1083.
    PubMed    


    April 2019
  53. RASMUSSEN JH, Lelkaitis G, Hakansson K, Vogelius IR, et al
    Intratumor heterogeneity of PD-L1 expression in head and neck squamous cell carcinoma.
    Br J Cancer. 2019 Apr 10. pii: 10.1038/s41416-019-0449.
    PubMed     Abstract available


  54. HADLER-OLSEN E, Wirsing AM
    Tissue-infiltrating immune cells as prognostic markers in oral squamous cell carcinoma: a systematic review and meta-analysis.
    Br J Cancer. 2019;120:714-727.
    PubMed     Abstract available


    March 2019
  55. PERE H, Pavie J, Pernot S, Veyer D, et al
    Comment on "Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis".
    Br J Cancer. 2019 Mar 26. pii: 10.1038/s41416-019-0439.
    PubMed    


  56. JAYARAJ R, Kumarasamy C
    Comment on "Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis".
    Br J Cancer. 2019 Mar 26. pii: 10.1038/s41416-019-0437.
    PubMed    


  57. GILBERT DC, Vale CL
    Reply to Comments on "Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis".
    Br J Cancer. 2019 Mar 26. pii: 10.1038/s41416-019-0440.
    PubMed    


  58. CRAIG SG, Anderson LA, Schache AG, Moran M, et al
    Recommendations for determining HPV status in patients with oropharyngeal cancers under TNM8 guidelines: a two-tier approach.
    Br J Cancer. 2019 Mar 20. pii: 10.1038/s41416-019-0414.
    PubMed     Abstract available


    February 2019
  59. CITRO S, Bellini A, Miccolo C, Ghiani L, et al
    Synergistic antitumour activity of HDAC inhibitor SAHA and EGFR inhibitor gefitinib in head and neck cancer: a key role for DeltaNp63alpha.
    Br J Cancer. 2019 Feb 15. pii: 10.1038/s41416-019-0394.
    PubMed     Abstract available


  60. GAO H, Aresu M, Vergnaud AC, McRobie D, et al
    Personal radio use and cancer risks among 48,518 British police officers and staff from the Airwave Health Monitoring Study.
    Br J Cancer. 2019;120:375-378.
    PubMed     Abstract available


    January 2019
  61. FLEMING JC, Woo J, Moutasim K, Mellone M, et al
    HPV, tumour metabolism and novel target identification in head and neck squamous cell carcinoma.
    Br J Cancer. 2019 Jan 17. pii: 10.1038/s41416-018-0364.
    PubMed     Abstract available


    December 2018
  62. LI Z, Liao J, Yang Z, Choi EY, et al
    Co-targeting EGFR and IKKbeta/NF-kappaB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancer.
    Br J Cancer. 2018 Dec 26. pii: 10.1038/s41416-018-0351.
    PubMed     Abstract available


  63. MA H, Yang W, Zhang L, Liu S, et al
    Interferon-alpha promotes immunosuppression through IFNAR1/STAT1 signalling in head and neck squamous cell carcinoma.
    Br J Cancer. 2018 Dec 17. pii: 10.1038/s41416-018-0352.
    PubMed     Abstract available


    November 2018
  64. GILBERT DC, Wakeham K, Langley RE, Vale CL, et al
    Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis.
    Br J Cancer. 2018 Nov 28. pii: 10.1038/s41416-018-0273.
    PubMed     Abstract available


    June 2018
  65. MEHRA R, Seiwert TY, Gupta S, Weiss J, et al
    Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012.
    Br J Cancer. 2018 Jun 29. pii: 10.1038/s41416-018-0131.
    PubMed     Abstract available


  66. KYLMA AK, Jouhi L, Listyarifah D, Mohamed H, et al
    Treponema denticola chymotrypsin-like protease as associated with HPV-negative oropharyngeal squamous cell carcinoma.
    Br J Cancer. 2018 Jun 22. pii: 10.1038/s41416-018-0143.
    PubMed     Abstract available


  67. RIVERA C, Zandonadi FS, Sanchez-Romero C, Soares CD, et al
    Agrin has a pathological role in the progression of oral cancer.
    Br J Cancer. 2018 Jun 6. pii: 10.1038/s41416-018-0135.
    PubMed     Abstract available


    May 2018
  68. GRONHOJ C, Jensen DH, Dehlendorff C, Marklund L, et al
    Development and external validation of nomograms in oropharyngeal cancer patients with known HPV-DNA status: a European Multicentre Study (OroGrams).
    Br J Cancer. 2018 May 24. pii: 10.1038/s41416-018-0107.
    PubMed     Abstract available


    March 2018
  69. MA B, Hui EP, King A, Leung SF, et al
    Prospective evaluation of plasma Epstein-Barr virus DNA clearance and fluorodeoxyglucose positron emission scan in assessing early response to chemotherapy in patients with advanced or recurrent nasopharyngeal carcinoma.
    Br J Cancer. 2018 Mar 20. pii: 10.1038/s41416-018-0026.
    PubMed     Abstract available


  70. JAYARAJ R, Kumarasamy C
    Comment on 'Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis'.
    Br J Cancer. 2018;118:e11.
    PubMed    


  71. ALMANGUSH A, Heikkinen I, Makitie AA, Coletta RD, et al
    Reply to 'Comment on 'Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis".
    Br J Cancer. 2018;118:e12.
    PubMed    


    February 2018
  72. ALMANGUSH A, Pirinen M, Heikkinen I, Makitie AA, et al
    Tumour budding in oral squamous cell carcinoma: a meta-analysis.
    Br J Cancer. 2018;118:577-586.
    PubMed     Abstract available


  73. YUZHALIN AE, Urbonas T, Silva MA, Muschel RJ, et al
    A core matrisome gene signature predicts cancer outcome.
    Br J Cancer. 2018;118:435-440.
    PubMed     Abstract available


  74. SHIMODAIRA Y, Slack RS, Harada K, Chen HC, et al
    Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trial.
    Br J Cancer. 2018;118:331-337.
    PubMed     Abstract available


  75. NIEMINEN MT, Listyarifah D, Hagstrom J, Haglund C, et al
    Treponema denticola chymotrypsin-like proteinase may contribute to orodigestive carcinogenesis through immunomodulation.
    Br J Cancer. 2018;118:428-434.
    PubMed     Abstract available


    January 2018
  76. MA H, Jin S, Yang W, Zhou G, et al
    Interferon-alpha enhances the antitumour activity of EGFR-targeted therapies by upregulating RIG-I in head and neck squamous cell carcinoma.
    Br J Cancer. 2018 Jan 18. pii: bjc2017442. doi: 10.1038/bjc.2017.
    PubMed     Abstract available


    November 2017
  77. HAYRY V, Kagedal A, Hjalmarsson E, Neves da Silva PF, et al
    Rapid nodal staging of head and neck cancer surgical specimens with flow cytometric analysis.
    Br J Cancer. 2017 Nov 21. doi: 10.1038/bjc.2017.
    PubMed     Abstract available


  78. KAWAKITA D, Lee YA, Gren LH, Buys SS, et al
    The impact of folate intake on the risk of head and neck cancer in the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO) cohort.
    Br J Cancer. 2017 Nov 21. doi: 10.1038/bjc.2017.
    PubMed     Abstract available


  79. SUN W, Wei FQ, Li WJ, Wei JW, et al
    A positive-feedback loop between tumour infiltrating activated Treg cells and type 2-skewed macrophages is essential for progression of laryngeal squamous cell carcinoma.
    Br J Cancer. 2017;117:1631-1643.
    PubMed     Abstract available


  80. SONG H, Saito E, Sawada N, Abe SK, et al
    Body mass index change during adulthood and risk of oesophageal squamous-cell carcinoma in a Japanese population: the Japan Public Health (JPHC)-based prospective study.
    Br J Cancer. 2017;117:1715-1722.
    PubMed     Abstract available


  81. WEI F, Wu Y, Tang L, He Y, et al
    BPIFB1 (LPLUNC1) inhibits migration and invasion of nasopharyngeal carcinoma by interacting with VTN and VIM.
    Br J Cancer. 2017 Nov 9. doi: 10.1038/bjc.2017.
    PubMed     Abstract available


  82. WERNER TA, Forster CM, Dizdar L, Verde PE, et al
    CXCR4/CXCR7/CXCL12 axis promotes an invasive phenotype in medullary thyroid carcinoma.
    Br J Cancer. 2017 Nov 7. doi: 10.1038/bjc.2017.
    PubMed     Abstract available


  83. BAE WJ, Koo BS, Lee SH, Kim JM, et al
    Inhibitor of DNA binding 2 is a novel therapeutic target for stemness of head and neck squamous cell carcinoma.
    Br J Cancer. 2017 Nov 2. doi: 10.1038/bjc.2017.
    PubMed     Abstract available


    October 2017
  84. PRAWIRA A, Oosting SF, Chen TW, Delos Santos KA, et al
    Systemic therapies for recurrent or metastatic nasopharyngeal carcinoma: a systematic review.
    Br J Cancer. 2017 Oct 24. doi: 10.1038/bjc.2017.
    PubMed     Abstract available


    September 2017
  85. ASTROM P, Juurikka K, Hadler-Olsen ES, Svineng G, et al
    The interplay of matrix metalloproteinase-8, transforming growth factor-beta1 and vascular endothelial growth factor-C cooperatively contributes to the aggressiveness of oral tongue squamous cell carcinoma.
    Br J Cancer. 2017;117:1007-1016.
    PubMed     Abstract available


  86. KOSHIARIS C, Aveyard P, Oke J, Ryan R, et al
    Smoking cessation and survival in lung, upper aero-digestive tract and bladder cancer: cohort study.
    Br J Cancer. 2017 Sep 12. doi: 10.1038/bjc.2017.
    PubMed     Abstract available


  87. BARZEGAR M, Ma S, Zhang C, Chen X, et al
    SKLB188 inhibits the growth of head and neck squamous cell carcinoma by suppressing EGFR signalling.
    Br J Cancer. 2017 Sep 5. doi: 10.1038/bjc.2017.
    PubMed     Abstract available


  88. ALMANGUSH A, Heikkinen I, Makitie AA, Coletta RD, et al
    Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis.
    Br J Cancer. 2017;117:856-866.
    PubMed     Abstract available


  89. ELMUSRATI AA, Pilborough AE, Khurram SA, Lambert DW, et al
    Cancer-associated fibroblasts promote bone invasion in oral squamous cell carcinoma.
    Br J Cancer. 2017;117:867-875.
    PubMed     Abstract available


    August 2017
  90. SCHUMACHER S, Bartenhagen C, Hoffmann M, Will D, et al
    Disseminated tumour cells with highly aberrant genomes are linked to poor prognosis in operable oesophageal adenocarcinoma.
    Br J Cancer. 2017;117:725-733.
    PubMed     Abstract available


  91. WADHWA R, Wang X, Baladandayuthapani V, Liu B, et al
    Nuclear expression of Gli-1 is predictive of pathologic complete response to chemoradiation in trimodality treated oesophageal cancer patients.
    Br J Cancer. 2017;117:648-655.
    PubMed     Abstract available


  92. REEH M, Ghadban T, Uzunoglu FG, Nentwich MF, et al
    Hamburg-Glasgow classification: preoperative staging by combination of disseminated tumour load and systemic inflammation in oesophageal carcinoma.
    Br J Cancer. 2017;117:612-618.
    PubMed     Abstract available


  93. HALL SF, Liu FF, O'Sullivan B, Shi W, et al
    Did the addition of concurrent chemotherapy to conventional radiotherapy improve survival for patients with HPV+ve and HPV-ve Oropharynx cancer? A population-based study.
    Br J Cancer. 2017 Aug 22. doi: 10.1038/bjc.2017.
    PubMed     Abstract available


  94. LEE JY, Garcia-Murillas I, Cutts RJ, De Castro DG, et al
    Predicting response to radical (chemo)radiotherapy with circulating HPV DNA locally advanced head and neck squamous carcinoma.
    Br J Cancer. 2017 Aug 15. doi: 10.1038/bjc.2017.
    PubMed     Abstract available


    July 2017
  95. SARASWAT M, Makitie A, Agarwal R, Joenvaara S, et al
    Oral squamous cell carcinoma patients can be differentiated from healthy individuals with label-free serum proteomics.
    Br J Cancer. 2017;117:376-384.
    PubMed     Abstract available


  96. LAJER CB, Garnaes E, Friis-Hansen L, Norrild B, et al
    The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer.
    Br J Cancer. 2017 Jul 13. doi: 10.1038/bjc.2017.
    PubMed     Abstract available


    June 2017
  97. SAMARENDRA H, Jones K, Petrinic T, Silva MA, et al
    A meta-analysis of CXCL12 expression for cancer prognosis.
    Br J Cancer. 2017;117:124-135.
    PubMed     Abstract available


  98. WAGNER S, Wittekindt C, Sharma SJ, Wuerdemann N, et al
    Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer.
    Br J Cancer. 2017;116:1604-1611.
    PubMed     Abstract available


  99. CUSTODIO A, Carmona-Bayonas A, Jimenez-Fonseca P, Sanchez ML, et al
    Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumab.
    Br J Cancer. 2017;116:1526-1535.
    PubMed     Abstract available


    May 2017
  100. BROWN TE, Banks MD, Hughes BGM, Lin CY, et al
    Randomised controlled trial of early prophylactic feeding vs standard care in patients with head and neck cancer.
    Br J Cancer. 2017 May 23. doi: 10.1038/bjc.2017.
    PubMed     Abstract available


  101. AMIT M, Tam S, Abdelmeguid AS, Roberts DB, et al
    Mutation status among patients with sinonasal mucosal melanoma and its impact on survival.
    Br J Cancer. 2017 May 11. doi: 10.1038/bjc.2017.
    PubMed     Abstract available


  102. WOZNY AS, Lauret A, Battiston-Montagne P, Guy JB, et al
    Differential pattern of HIF-1alpha expression in HNSCC cancer stem cells after carbon ion or photon irradiation: one molecular explanation of the oxygen effect.
    Br J Cancer. 2017;116:1340-1349.
    PubMed     Abstract available


    April 2017
  103. SUH YE, Lawler K, Henley-Smith R, Pike L, et al
    Association between hypoxic volume and underlying hypoxia-induced gene expression in oropharyngeal squamous cell carcinoma.
    Br J Cancer. 2017;116:1057-1064.
    PubMed     Abstract available


    March 2017
  104. PETRICK JL, Kelly SP, Liao LM, Freedman ND, et al
    Body weight trajectories and risk of oesophageal and gastric cardia adenocarcinomas: a pooled analysis of NIH-AARP and PLCO Studies.
    Br J Cancer. 2017;116:951-959.
    PubMed     Abstract available


  105. CROSBY T, Hurt CN, Falk S, Gollins S, et al
    Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/- cetuximab in oesophageal cancer.
    Br J Cancer. 2017;116:709-716.
    PubMed     Abstract available


    February 2017
  106. SUNDQUIST E, Kauppila JH, Veijola J, Mroueh R, et al
    Tenascin-C and fibronectin expression divide early stage tongue cancer into low- and high-risk groups.
    Br J Cancer. 2017;116:640-648.
    PubMed     Abstract available


  107. HALL PS, Lord SR, Collinson M, Marshall H, et al
    A randomised phase II trial and feasibility study of palliative chemotherapy in frail or elderly patients with advanced gastroesophageal cancer (321GO).
    Br J Cancer. 2017;116:472-478.
    PubMed     Abstract available


    January 2017
  108. LEFEVRE M, Rousseau A, Rayon T, Dalstein V, et al
    Epithelial to mesenchymal transition and HPV infection in squamous cell oropharyngeal carcinomas: the papillophar study.
    Br J Cancer. 2017;116:362-369.
    PubMed     Abstract available


  109. WELSH L, Panek R, Riddell A, Wong K, et al
    Blood transfusion during radical chemo-radiotherapy does not reduce tumour hypoxia in squamous cell cancer of the head and neck.
    Br J Cancer. 2017;116:28-35.
    PubMed     Abstract available


    October 2016
  110. COOK MB, Drahos J, Wood S, Enewold L, et al
    Pathogenesis and progression of oesophageal adenocarcinoma varies by prior diagnosis of Barrett's oesophagus.
    Br J Cancer. 2016 Oct 25. doi: 10.1038/bjc.2016.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: